Inventiva and AbbVie extend agreement for drug discovery

Inventiva and AbbVie extend agreement for drug discovery: Inventiva, a biopharmaceutical company developing innovative therapies, particularly in fibrosis, has extended its agreement with AbbVie to continue discovery and development efforts for orally available RORγ inverse agonists